Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Kirkland, WA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Tacoma, WA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Loma Linda, CA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Orlando, FL
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Hershey, PA
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Evansville, IN
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Dallas, TX
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Oviedo, FL
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Oviedo, FL
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Farmington Hills, MI
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Spokane, WA
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Hallandale Beach, FL
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Durham, NC
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Cleveland, OH
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated:  12/21/2017
Clinical Research Facility
mi
from
Washington,
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease
Status: Enrolling
Updated: 12/21/2017
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US101
mi
from
Phoenix, AZ
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US101
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US102
mi
from
Ann Arbor, MI
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US102
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US108
mi
from
Pensacola, FL
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US108
mi
from
Pensacola, FL
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US106
mi
from
Columbus, GA
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US106
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US107
mi
from
Indianapolis, IN
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US107
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US118
mi
from
Simi Valley, CA
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US118
mi
from
Simi Valley, CA
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US117
mi
from
Temecula, CA
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US117
mi
from
Temecula, CA
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US115
mi
from
Boca Raton, FL
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US115
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US109
mi
from
Hallandale Beach, FL
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US109
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US116
mi
from
Miami, FL
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US116
mi
from
Miami, FL
Click here to add this to my saved trials
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated:  12/22/2017
US111
mi
from
Columbus, OH
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia
Status: Enrolling
Updated: 12/22/2017
US111
mi
from
Columbus, OH
Click here to add this to my saved trials
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Status: Enrolling
Updated:  1/8/2018
Oregon Health and Science University
mi
from
Portland, OR
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Status: Enrolling
Updated: 1/8/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated:  1/8/2018
Birmingham VAMC
mi
from
Birmingham, AL
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated: 1/8/2018
Birmingham VAMC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated:  1/8/2018
Atlanta VA Medical Center
mi
from
Decatur, GA
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated: 1/8/2018
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated:  1/8/2018
Clinical Research Facility
mi
from
Portland, OR
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated: 1/8/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated:  1/8/2018
mi
from
Toronto,
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
Status: Enrolling
Updated: 1/8/2018
mi
from
Toronto,
Click here to add this to my saved trials
Web-based Genetic Research on Parkinson's Disease
Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives
Status: Enrolling
Updated:  1/9/2018
Www.23Andme.Com/Pd
mi
from
Mountain View, CA
Web-based Genetic Research on Parkinson's Disease
Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives
Status: Enrolling
Updated: 1/9/2018
Www.23Andme.Com/Pd
mi
from
Mountain View, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Birmingham, AL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Phoenix, AZ
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Sun City, AZ
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Sun City, AZ
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Fountain Valley, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Pasadena, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Reseda, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Reseda, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Sacramento, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Torrance, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Ventura, CA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Ventura, CA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Aurora, CO
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Manchester, CT
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Manchester, CT
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Boca Raton, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Gainesville, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Naples, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Port Charlotte, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
mi
from
Sunrise, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials